Hot topics
Event Schedule
Day one
08:30 Joining to the online platform
08:45 Greeting from the Project Lead & GLC Icebreaker Session
08:55 Opening Remarks from the Chair
09:00 Sponsor Speech
09:15 How can RWE support Market Access team(s) in a post COVID landscape
09:45 Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
10:15 Advanced analytics and RWE needs of HTA s/payers for Managed Entry
10:45 Coffee Break
11:00 Market access in Alzheimer’s Disease
11:30 Do Value Based Contract support access to Rare Diseases?
12:00 Speed Date Networking Session
12:20 Lunch Break
13:00 What are the challenges of achieving greater collaboration among payers, HTAs, patients and pharma?
13:30 PANEL DISCUSSION: Philanthropy, social responsibility and drug pricing
14:10 Breath some fresh air
14:30 Same same, but different’: Entering the Rare Disease space – some considerations for a successful launch
15:00 What is the real value of pharmaceutical products in the digital era?
15:30 Closing remarks from the Chair
15:45 End of Day 1
Day two
08:45 Joining to the Online Platform
08:55 Opening Remarks from the Chair
09:00 How the payer is evolving in pricing innovation : value based agreements, indication based pricing and game theory smart deals!
09:30 New pricing and Reimbursement models for advanced therapies
10:00 Round Table Discussion- How to achieve the shift from Volume-based to Value-based Market Access in the EU?
10:30 Let’s grab a coffee
11:00 RWE for orphan Drugs in Germany
11:30 Speaker Q&A
12:00 Reaching a better integration of regulatory pathways
12:30 Lunch Break
13:30 : e-pharma: the revolution to drug market access
14:00 Equal access and multi-indication medicines
14:30 Entering the bio-digital revolution, an age of transformative disruption
15:00 Farewell Networking Session
15:20 Closing remarks from the Chair
15:30 End of Day 2
For detailed program request the agenda
Get to know our renowned speakers
Who will you meet?
VPs, Global Head, Heads, Director, Managers OF:
- Market Access
- Commercial Pricing
- Pricing & Reimbursement Strategy
- Health Economics & Outcomes Research
- Regulatory Affairs
- Governmental Affairs
- Public Affairs
- Public Policy Operations
- Payer Insights
- Real World Evidence
- Patient Access
- Corporate Affairs
- HEOR
- Medical Affairs International Cooperation
- Strategic Development Policy & Reimbursement
- Marketing Business Intelligence
- Value Insight & Communication
- Real World Evidence Solutions
- HTA Strategy
- HTA Policy
- Value Access
Interested in more event information?
>>> or see more event details
- Past event videos
- Speaker panel
- Reasons to attend
- Sponsors
- Who will you meet
- Media partners
- Previous clients
- Venue and travel information
- Frequently Asked Questions
